Phytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngology

Abstract

Phytotherapeutic pharmaceuticals and herbal medicinal products with its roots in classical phytotherapeutic medicine have a well-established role in otolaryngological therapy, especially for diseases of the upper airways and acute and chronic infections. A thorough selection and application could mean huge benefit for the patient, in particular in cases with contraindications, chemo- and antibiotic resistance or patient request. Besides, it might spare other medications. Phytotherapeutic pharmaceuticals must fulfil the same criteria of quality, effectiveness and harmlessness of evidence-based medicine like chemical pharmaceuticals, although they are often prescribed due to its well established or traditional based use. This review focuses on phytotherapeutic therapies well established within the European Community for otolaryngologic disease patterns by referring to clinical studies or meta-analysis.

Introduction

Henri Leclerc (1870–1955) introduced the terminology of phytotherapy into medical science. Natural products were used in non-scientific manner before. People experienced natural products as being helpful for their health and learned to treat illnesses disease-specific. Therefore, it is appropriate to discuss phytotherapeutic and naturopathic adjuvant therapies in a disease oriented manner. Phytopharmaceuticals consist of a main ingredient that is responsible for the main mechanism of efficacy and of auxiliary agents, backing agents (effecting pharmacokinetics) and structure stabilizing agents. Often phytotherapeutic pharmaceuticals are composed of numerous herbal products or agents increasing medical effectiveness.

Generally speaking, phytopharmaceuticals are not used in emergency medicine and acute care medicine, but are indicated in diseases of mild to intermediate severity, in particular in cases of functional or chronic diseases. Adjuvant or co-therapy, relapse prevention, reconvalescence and unverified disorders are other indications for phytopharmaceuticals.

In contrast to chemical pharmaceuticals, phytotherapeutics possess a wider therapeutic range, lesser adverse reactions and less interactions with other pharmaceuticals. As well as in chemical pharmaceuticals, thoroughly underdosage, false applications and application duration have to be regarded and overestimation of effectiveness has to be avoided. Administration form and usage have to be tailored to the individual patient needs (Table 1). Consequently, adequate diagnostic means must proceed the administration of phytopharmaceuticals.

Table 1 Mode of preparation and administration form of phytotherapeutics

Evidence-based medicine has entered phytotherapeutic medicine as well and therefore its benefits and advantages have been established in clinical studies and meta-analysis in the last years. In addition, due to the long tradition of phytotherapy individual-based and experienced-based medicine provide the basis for consideration of off-label-use in cases where clinical studies are missing.

Acute and chronic rhinosinusitis

In otolaryngology, phytopharmaceuticals which combine secretolytic, mucolytic, mucous membrane detumescing, secretomotoric, antiphlogistic and antimicrobial properties are classically used in diseases of the upper airways. Nose douches or inhalations with Emser brine or chamomile flower solutions represent usually the basal treatment in banal or allergic rhinitis. In addition, applied nasal sprays with seawater and chamomile avoid privinism. Essential oils of eucalyptus leaf and branch (Eucalyptus globulus, E. polybractea or E. smithii, Myrtaceae), peppermint leaf (Mentha piperita, Lamiaceae), mugo pine (Pinus mugo, Pinaceae) have secretolytic and antimicrobial effects, but should not be applied in infants due to the danger of laryngo- or bronchospasm (Kratschmer reflex). Together with its ingredients, menthol, camphor and 1,8-cineol they depolarize the thermoreceptors by inhibition of the calcium influx (Table 2) and lead to a subjective improvement of airflow although the nasal resistance is not decreased [1]. Systemic administered phytopharmaceuticals containing essential oils like GeloMyrtol® gastro-resistant capsules (standardized to contain not less than 30 mg limonene, 30 mg cineol and 8 mg alpha-pinene, manufactured by G. Pohl-Boskamp GmbH & Co KG, Hohenlockstadt, Germany) have shown increase of the mucociliary secret transport velocity by 28% and of the secretolysis by 30% [2]. GeloMyrtol® is administered in acute and chronic rhinosinusitis and after operations of the paranasal sinuses as well (Table 3) [3]. The combination herbal medicine Sinupret® contains powdered herbal extracts of European elder flower (Sambucus nigra, Caprifoliaceae), garden sorrel herb (Rumex acetosa, Polygonaceae), cowslip flower (Primula veris, Primulaceae), European vervain herb (Verbena officinalis, Verbenaceae), gentian root (Gentiana lutea, Gentianaceae) and liquefies the nasal mucous and secretions and acts antiphlogistic as well. A meta-analysis has shown that alternate application of GeloMyrtol® and Sinupret® has best benefits in acute and chronic rhinosinusitis [4] and can be used in pregnancy, too [5]. Besides Sinupret® and GeloMyrtol® can be used in acute and chronic bronchitis [6] and it could be shown that the efficacy of Sinupret® is superior to ambroxol and n-acetylcysteine [79]. It could be shown that Tesalin N® film tablets (containing a CO2-extract, Ze 339, of purple butterbur leaf (Petasites hybridus, Asteraceae), manufactured by Zeller Medical AG, Romanshorn, Switzerland) are as effective as fexofenadin and cetirizin in allergic rhinitis [10, 11]. A meta-analysis showed equivalent effectiveness when compared with non-sedative antihistamines [12].

Table 2 Phytotherapeutic therapy of upper airway and deglutition tract infections
Table 3 Discussed phytotherapeutic pharmaceuticals and their indication, administration form and dose

Acute and chronic laryngopharyngitis

About 50–70% of acute infections of the pharyngolaryngeal spaces are of viral pathogenesis [1315]. Therapeutic considerations of antibiotics with regards to microbial etiology starting point and duration of application or cost-effectiveness have been discussed extensively. Generally speaking, antibiotics have to be applied, whenever complications occur. Typically, gurgle solutions with sage leaf (Salvia officinalis, Lamiaceae), thyme herb (Thymus vulgaris, Lamiaceae) or chamomile flower (Matricaria recutita, Asteraceae) are applied in acute laryngopharyngitis. Imupret® dragees or drops (a combination herbal medicine manufactured by Bionorica AG, Neumarkt, Germany) can be used in chronic tonsillitis, tracheitis or in adenoid hyperplasia and acts antiphlogistic, astringent and immunomodulating. It contains aqueous-alcoholic extracts of marshmallow roots (Althaea officinalis, Malvaceae), chamomile flower, oak bark (Quercus robur, Q. Petraea, Q. pubescens, Fagaceae), English walnut leaves (Juglans regia, Juglandaceae), dandelion herb (Taraxacum officinale, Asteraceae), horsetail herb (Equisetum arvense, Equisetaceae) and yarrow flower (Achillea millefolium, Asteraceae) [16]. Two important phytotherapeutics with antimicrobial qualities are garden nasturtium haulm (Tropaeolum majus, Tropaeolaceae) and horseradish root (Armoracia rusticana, Brassicaceae) which contain mustard oils that have antibacterial properties against grampositive and gramnegative strains, virostatic and antimycotic effects and can be used when antibiotics should be avoided. The combination herbal medicine Angocin® (film tablets, manufactured by REPHA GmbH Biologische Arzneimittel, Langenhagen, Germany) uses synergistic effects of these two herbs. In particular, efficacy against Pseudomonas species has been proven and studies showed equivalent efficacy compared with standard antibiotics [1719]. Willow bark (Salix purpurea, S. daphnoides, S. fragilis, Salicaceae) decreases the body temperature directly due to its main ingredient salicin which in contrast to acetylsalicylic acid (ASA) lacks the acetyl-group and therefore has no adverse reactions in regards with stomach mucosa and platelet aggregation. Standardized willow bark extracts has comparable antiinflammatory activities as higher doses of ASA and shows antinociceptive and antipyretic effects [20]. Besides European elder berry (Sambucus nigra, Caprifoliaceae) and lime flower tea (Tilia platyphyllos, T. cordata, T. vulgaris, Tiliaceae) are often used to reduce body temperature and it could be shown that elder berry preparations reduce symptoms and illness duration 4 days faster when compared with placebo syrup in influenza A and B infections [21]. Marigold (Calendula officinalis, Asteraceae) and pelargonium root (Pelargonium sidoides, Geraniaceae) are successfully used in the treatment of upper infections of the respiratory tract and for acute and chronic tonsillitis as well [22, 23]. They have antibacterial, antiviral and secretolytic functions, but have to be applied in tonsillitis off-label as clinical data are not sufficient [24, 25].

Cough

Acute and chronic cough impair the general condition and should often be avoided after chirurgical interventions. Suppressing the need to cough can be achieved by physical and pharmacological measures. Main physical supporting measures include intake of fluids by drinking, inhalation and air humidification. A productive cough is often preceded by a dry and painful cough. Different phytotherapeutics have to be used in these disease stadiums. Opium alkaloids like codeine or noscapine have a direct antitussive effect on the CNS cough center in the medulla oblongata and the sensory nerves in the lower airways. They are applied in the phase of dry cough and mainly administered at night and only for a short time. Alternatively, phytopharmaceuticals that possess an antitussive and abirritative effect by contain polysaccharides that swell with water and produce a mucous layer inhibiting the hyperactive ciliary activity can be applied in dry cough. These phytopharmaceuticals usually contain marshmallow leaf or root (Althaea officinalis, Malvaceae), ribwort plantain leaf (Plantago lanceolota, Plantaginaceae) or iceland moss thallus (Cetraria islandica, Parmeliaceae). A productive cough should be treated with expectorations like cowslip flower (Primula veris, Primulaceae), thyme herb, English ivy leaf (Hedera helix, Araliaceae) or mullein flower (Verbascum densiflorum, V. phlomoides, V. thapsus) [26]. Syrup can be used for children [27]. These plants contain saponins which decrease mucous viscosity by decreasing the surface tension of water, increase ciliary activity and possess an antiphlogistic and bronchospasmolytic effect [28]. A combination of both mucous-releasing and secretolytic acting ingredients can be used in an intermediate cough state, e.g. Equisil® N Syrup (containing extracts of cowslip flower, mullein flower, thyme herb and ribwort plantain leaf, manufactured by Dr. Gustav Klein GmbH & Co KG, Zell am Hamersbach, Germany). Various studies have shown similar or superior effects of phytopharmaceutical expectorations compared to acetylcysteine or ambroxol. Prospan®, a dried ivy leaf extract (drops, liquid, syrup or tablets, manufactured by Engelhard Arzneimittel, Niederdorfelden, Germany), showed superiority to acetylcysteine [29] and Bronchipret® film tablets (dried alcoholic extracts of primula root and thyme herb, manufactured by Bionorica AG, Neumarkt, Germany) showed equivalency to ambroxol and n-acetylcysteine [30, 31]. In addition, essential mint oils due to its secretolytic effects can be inuncted or inhaled. They are well reabsorbed by the skin, e.g. as warm thorax compresses in pseudocroup. Menthol, camphor, 1,8-cineol activate the cold receptors in the larynx and have an antitussive and negative inspiratory effect [32].

Herpese simplex infection and stomatitis

It could be shown that lomaherpan® cream (manufactured by Rudolf Lohmann GmbH KG, Emmerthal, Germany) which contains dried extract of lemon balm leaf (Melissa officinalis, Lamiaceae) can be used for prophylaxis and is as effective as acyclovir when administered in the first 8 h in herpes simplex infections [33]. Besides, healing is faster and recurrences are reduced [34, 35]. Another study showed that rhubarb-sage cream is as effective as acyclovir [36]. Other therapeutics and preparations that have been effective in herpes simplex infections are propolis [37], ozonated olive oil or essential oils with thyme herb, chamomile flower, ginger root, peppermint leaf, eucalyptus leaf and tea tree foliage (Melaleuca alternifolia, M. dissitiflora, M. linariifolia, Myrtaceae) [3840]. Topical medications, such as mouth-washes and topical corticosteroids can achieve the primary goal to reduce pain and to improve healing time but do not improve recurrence or remission rate in recurrent aphthous stomatitis. It could be shown that myrtle (Myrtus communis, Myrtaceae) reduces ulcer size, pain severity, erythema and exudation level **in recurrent aphthous stomatitis [41], and a daily intake of 500 mg bee propolis could reduce the outbreaks in recurrent aphthous stomatitis [42]. Candidiasis or thrush can be effectively treated with solutions or tinctures of chamomile flower, myrtle, sage leaf, or thyme herb [43]. Besides, essential oil of thyme herb potentiates the antifungal effect of amphotericin B in culture [44]. In addition, maloudor in cancer patients improves significantly and ulcer healing benefits after essential oil application (in this study an essential oil mix based on eucalyptus was applied twice daily) [45]. Besides, astringencies who have antiinflammatory, weak antiseptic effects and increase tissue repair like arnica flower (Arnica montana, Asteraceae), mulberry leaves (Morus alba, Moraceae) and silverweed (Argentina anserina, Rosaceae) are used in stomatitis, as well as aromatica (essential oil drugs) with its antiphlogistic and antimicrobial effects like clove flower bud (Syzygium aromaticum, Myrtaceae), calendula flower or rose blossom (Rosa spp., Rosaceae) [46].

Acute otitis media

About 50% of all acute middle ear infections are of viral pathogenesis [47]. Antibiotic usage in uncomplicated acute otitis media in children has been discussed controversial recently [48, 49]. It has been advocated that a watchful waiting period of 2–3 days is adequate before administering antibiotics [50]. However, antibiotics have to be applied whenever complications occur. To reduce the pain, a hot chamber that can be simple made by hot washcloth and a bathing cap is often very helpful. The American Academy of Otolaryngology-Head and Neck Surgery guidelines recommend topical medications as the first line of treatment for ear pain in the absence of systemic infection or serious underlying disease. There is some evidence that in the management of ear pain topical combination herbal medicines (e.g. Otikon otic solution containing extracts of garlic bulb, mullein flower, calendula flower and St. John’s wort herb in olive oil, manufactured by Healthy-On Ltd., Petach-Tikva, Israel) are as effective as oral amoxicillin and topical anaesthetics due to its antimicrobial, antiinflammatory, immunostimulating effects and good penetration through the tympanic membrane [51, 52]. Generally speaking, the dosage for phytotherapeutic drugs in children can be estimated for children under 4 years of age with 1/3 of the dosage for adults, children to 10 years take 1/2 and children to 16 years take 2/3 of the adult dosage.

Otitis externa diffusa

Infections of the outer ear canal are often only controlled when systemically and locally treated with longer application duration at the same time. First, cerumen and detritus have to be sucked from the outer ear canal to avoid a growing medium. Phytopharmaceuticals can be of adjuvant benefit for these patients often suffering from systemic diseases as well. Above-mentioned antiviral, antimycotic and antibacterial tinctures, drops or solutions are very useful in otitis externa as well, e.g. otikon ear drops, essential oil drugs, melissae or myrtle tinctures (Lomaherpan®, lomastatin®).

Reflux disease

The importance of gastroesophageal reflux in the aetiopathogenesis for various diseases of the upper airways and deglutition pathways, including cancerogenesis, is well known in otolaryngology. Reflux disease with a prevalence of up to 20% is a common symptom in western civilizations and can be the reason for other symptoms as globus pharyngis, postnasal drip, cough or halitosis [53]. Besides gastroesophageal reflux affects wound healing negatively. A tea spoon of healing earth (e.g. Luvos®, Heilerde-Gesellschaft Luvos Just GmbH & Co KG) equating 6.5 g has an acid-binding capacity of 25 mVal that is recommended for an antacidum from the German Federal Institute for Drugs and Medical Devices (BfArM). Asian ginseng root (Panax ginseng, Araliaceae) can be used in chronic erosive esophagitis [54] and possesses anticancerogenic effects [55].

Wound care

Acute and chronic wounds benefit from adjuvant phytotherapeutic and naturopathic care, although further research has to be done in this field. In vitro studies have shown the stimulation of keratinocytes cell proliferation of bee propolis in wound healing [56]. Meta-analyses have shown that medical grade honey (Medihoney, standardized antibacterial honey) is suitable as alternative for wound healing, burns, oral and external surgical wounds, various skin conditions and in the cancer setting, e.g. applied for radiation-induced mucositis, radiotherapy-induced skin reactions, hand and foot skin reactions in chemotherapy [5759]. Ozone or ozonated olive oil application has been used for many years as a method ancillary to basic treatment in acute or chronic wounds, especially in those cases in which traditional treatment methods do not give satisfactory results, e.g. skin loss in non-healing wounds, ulcers, pressure sores, fistulae, etc. [6063]. Besides, essential oils represent a cheap and antiseptic effective treatment option for antibiotic-resistant strains of MRSA and antimycotic-resistant Candida species [64]. Calendula flower has antiphlogistic, immunostimulating, cytotoxic, antimicrobial, antiedematous, lymphagogue, phagocytosis and granulocytosis increasing effects and is successfully applied topically and systemic in the prevention and treatment of radiation dermatitis, venous ulcers and postoperative wounds [6569].

Immunomodulation and immunostimulation

The terminology of immunomodulation should be preferred to immunostimulation as many phytotherapeutics used for a longer time or used in systemic and autoimmune diseases can lead to immunodepression. Therefore, coneflower root (Echinacea spec., Asteraceae) should not be applied longer than 8 weeks in adults and 2 weeks in children at a stretch. Echinacea and combination medicines (e.g. Esberitox®, manufactured by Schaper & Bruemmer GmbH & Co KG, Salzgitter, Germany or Contramutan®N, manufactured by A. Nettermann & Cie. GmbH, Cologne, Germany) can be used in all acute infections and is helpful in acute laryngopharyngitis, in particular [70, 71]. It enhances cell-mediated immunity by stimulation of macrophages, natural killer cells and granulocytes as well as humoral immunity through monokines, interferons and the complement system. Further herbs used for immunomodulating combination herbal medicines or single preparations are thuja herb (Thuja occidentalis, Cupressaceae), hemp agrimony (Eupatorium cannabinum, Asteraceae), boneset (Eupatorium perfoliatum, Asteraceae), wild indigo root (Baptisia tintoria, Fabaceae), lime flower, European elder berry, chamomile flower, meadowsweet herb (Filipendula ulmaria, Rosaceae) and pelargonium root (Pelargonium sidoides, Geraniaceae). Besides, it could be shown that Asian ginseng root (Panax ginseng, Araliaceae) accelerates reconvalescence, body weight, leukocytes and serum protein after operations and radiotherapy [72].

Vertigo and kinetosis

Scopoderm is a transdermal patch contain pure scopolamine, an alkaloid of belladonna leaves. It should be administered 4–6 h before the start of a journey. Equivalent effects for motion sickness (kinetosis) have been shown for ginger rhizome (zingiber officinale, Zingiberaceae) [73, 74]. Besides, ginger is well known for nausea and vomiting in pregnancy and postoperative care. Numerous trials, reviews and meta-analyses have shown equivalent efficacy when compared with hydrochloride (vitamin B6) and metoclopramide [7580]. Extracts of Gingko leaves (Gingko biloba, Gingkoaceae) have positive effects on the microcirculation and can be effectively used in long-time therapy for vestibular vertigo [81, 82].

Conclusion

Phytotherapeutic pharmaceuticals and herbal medicinal products with its roots in classical phytotherapeutic medicine have a well-established role in otolaryngological therapy within the European Community. A thorough selection and application can mean huge benefit for the patient, in particular in cases with contraindications, chemo- and antibiotic resistance or patient request. In complicated cases of upper airway or ear infections chemical antibiotics are indicated, but phytopharmaceuticals can be of additive value. In cases, where clinical studies and meta-analysis are missing, the long tradition of individual-based and experienced-based medicine provide the basis for therapeutical consideration.

References

  1. 1.

    Fox N (1927) Effect of camphor, eucalyptol, and menthol on the vascular state of the mucous membrane. Arch Otolaryngol Head Neck Surg 6:112–122

    Article  Google Scholar 

  2. 2.

    Behrbohm H, Kaschke O, Sydow K (1995) Effect of phytogenic secretolytic drug Gelomyrtol forte on mucociliary clearance of the maxillary sinus. Laryngorhinootologie 74:733–737

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Federspil P, Wulkow R, Zimmermann T (1997) Effects of standardized myrtol in therapy of acute sinusitis-results of a double-blind, randomized multicenter study compared with placebo. Laryngorhinootologie 76:23–27

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Melzer J, Saller R, Schapowal A, Brignoli R (2006) Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forschende Komplementärmedizin 13:78–87 (German)

    PubMed  Article  Google Scholar 

  5. 5.

    Ismail C, Wiesel A, März RW, Queisser-Luft A (2002) Surveillance study of Sinupret in comparison with data of the Mainz birth registry. Arch Gynecol Obstet 267:196–201

    PubMed  Google Scholar 

  6. 6.

    Meister R, Wittig T, Beuscher N, deMey C (1999) Efficacy and tolerability of myrtol standardized in long term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study group investigators. Arzneimittelforschung 49:351–358 (German)

    PubMed  CAS  Google Scholar 

  7. 7.

    Ernst E, März RW, Sieder C (1997) Acute bronchitis: effectiveness of Sinupret. Comparative study with common expectorants in 3187 patients. Fortschr Med 115:52–53 (German)

    PubMed  CAS  Google Scholar 

  8. 8.

    März RW, Ismail C, Popp MA (1999) Profile and effectiveness of a phytogenic combination preparation for treatment of sinusitis. Wien Med Wochenschr 149:202–208 (German)

    PubMed  Google Scholar 

  9. 9.

    Matthys H, deMey C, Carls C, Geib A, Wittig T (2000) Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung 50:700–711 (German)

    PubMed  CAS  Google Scholar 

  10. 10.

    Schapowal A (2002) Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. BMJ 324:144–146

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Schapowal A (2004) Butterbur Ze339 for the treatment of intermittent allergic rhinitis: dose-dependent efficacy in a prospective, randomized, double-blind, placebo-controlled study. Arch Otolaryngol Head Neck Surg 130:1381–1386

    PubMed  Article  Google Scholar 

  12. 12.

    Guo R, Pittler MH, Ernst E (2007) Herbal medicines tor the treatment of allergic rhinitis: a systematic review. Ann Asthma Allergy Immunol 99:483–495

    Article  Google Scholar 

  13. 13.

    Chi H, Chiu NC, Li WC, Huang FY (2003) Etiology of acute pharyngitis in children: is antibiotic therapy needed. J Microbiol Immunol Infect 36:26–30

    PubMed  Google Scholar 

  14. 14.

    Eposito S, Blasi F, Bosis S (2004) Aetiology of acute pharyngitis: the role of atypical bacteria. J Med Microbiol 53:645–651

    Article  Google Scholar 

  15. 15.

    Gerber MA (2005) Diagnosis and treatment of pharyngitis in children. Pediatr Clin North Am 52:729–747

    PubMed  Article  Google Scholar 

  16. 16.

    Berger T (2008) Tolerability and efficacy of a herbal combination preparation in children and adolescents with recurrent infections of the upper respiratory tract. MMW Fortschr Med 150:85–90 (German)

    PubMed  Google Scholar 

  17. 17.

    Conrad A, Kolberg T, Engels I, Frank U (2006) In vitro study to evaluate the antibacterial activity of a combination of the haulm of nasturtium (Tropaeoli majoris herba) and of the roots of horseradish (Armoraciae rusticanae radix). Arzneimittelforschung 56:842–849 (German)

    PubMed  CAS  Google Scholar 

  18. 18.

    Goos KH, Albrecht U, Schneider B (2006) Efficacy and safety profile of a herbal drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in comparison with other treatments in the daily practice/results of a prospective cohort study. Arzneimittelforschung 56:249–257 (German)

    PubMed  CAS  Google Scholar 

  19. 19.

    Goos KH, Albrecht U, Schneider B (2007) On-going investigations on efficacy and safety profile of a herbal drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in children in comparison with other antibiotic treatments. Arzneimittelforschung 57:238–246 (German)

    PubMed  CAS  Google Scholar 

  20. 20.

    März RW, Kemper F (2002) Willow bark extract-effects and effectiveness. Status of current knowledge regarding pharmacology, toxicology and clinical aspects. Wien Med Wochenschr 152:354–359 (German)

    PubMed  Article  Google Scholar 

  21. 21.

    Zakay-Rones Z, Thom E, Wollan T, Wadstein J (2004) Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res 32:132–140

    PubMed  CAS  Google Scholar 

  22. 22.

    Matthys H, Eisebitt R, Seith B, Heger M (2003) Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine 10:7–17

    PubMed  Article  Google Scholar 

  23. 23.

    Matthys H, Kamin W, Funk P, Heger M (2007) Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children. Phytomedicine 14(Suppl 6):69–73

    PubMed  Article  Google Scholar 

  24. 24.

    Conrad A, Kolodziej H, Schulz V (2007) Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety. Wien Med Wochenschr 157:331–336 (German)

    PubMed  Article  Google Scholar 

  25. 25.

    Kolodziej H, Schulz V (2003) Umckaloabo. Deutsche Apotheker Zeitung 143:55–64 (German)

    Google Scholar 

  26. 26.

    Beer AM, Loew D (2008) Medical plants for infections of the upper and lower airway tract: practical recommendations. MMW Fortschr Med 150:29–33 (German)

    PubMed  Google Scholar 

  27. 27.

    Marzian O (2007) Treatment of acute bronchitis in children and adolescents. Non interventional postmarketing surveillance study confirms the benefit and safety of a syrup made of extracts from thyme and ivy leaves. MMW Fortschr Med 149:69–74 (German)

    PubMed  Google Scholar 

  28. 28.

    Schilcher H, Kammerer S, Wegener T (2007) Praxisleitfaden phytotherapie. Urban und Fischer, München (German)

    Google Scholar 

  29. 29.

    Bolbot Y, Prokhorov E, Mokia S, Yurtseva A (2004) Comparing the efficacy and safety of high-concentrate ivy leaves extract and acetylcysteine for treatment of children with acute bronchitis. Drugs of Ukraine 11

  30. 30.

    Ernst E, März R, Sieder C (1997) A controlled multi-centre study of herbal versus synthetic secretolytic drugs for acute bronchitis. Phytomedicine 1:287–293

    Article  Google Scholar 

  31. 31.

    Ismail C, Willer G, Steindl H (2003) Bronchipret in acute bronchitis. Schweizerische Zeitschrift für Ganzheitsmedizin 15:171–175 (German)

    Google Scholar 

  32. 32.

    Abe J, Hosokawa H, Sawada Y, Matsumura K, Kobayashi S (2006) Ca2+-dependent PKC activation mediates menthol-induced desensitization of transient receptor potential M8. Neurosci Lett 397:140–144

    PubMed  Article  CAS  Google Scholar 

  33. 33.

    Mohrig A, Alken RG (1996) Melissa extract in comparison to acyclovir. Pharmazeutische Rundschau 38:25–26 (German)

    Google Scholar 

  34. 34.

    Wölbling RH, Leonhardt K (1994) Local therapy of herpes simplex with dried extract from Melissa officinalis. Phytomedicine 1:25–31

    Article  Google Scholar 

  35. 35.

    Köhler K (1997) Extract from Melissa officinalis in herpes simplex. Effectivity against placebo proofed again. Allgemeinarzt 19:1853–1854 (German)

    Google Scholar 

  36. 36.

    Buechi S (2005) Sage leaves and pieplant roots vs acyclovir in herbes labialis. Zeitschrift für Phytotherapie 26:275–277 (German)

    Article  Google Scholar 

  37. 37.

    Vynograd N, Vynograd I, Sosnowski Z (2000) A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV). Phytomedicine 7:1–6

    PubMed  Article  CAS  Google Scholar 

  38. 38.

    Koch C, Reiching J, Schneele J, Schnitzler P (2008) Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine 15:71–78

    PubMed  Article  CAS  Google Scholar 

  39. 39.

    Nolkemper S, Reichling J, Stintzing FC (2006) Antiviral effect of aqueous extracts from species of the Lamiaceae family against herpes simplex virus type 1 and type 2 in vitro. Plant Med 72:1378–1382

    Article  CAS  Google Scholar 

  40. 40.

    Schnitzler P, Schön K, Reichling J (2001) Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Die Pharmazie 56:343–347 (German)

    PubMed  CAS  Google Scholar 

  41. 41.

    Babaee N, Mansourian A, Momen-Haravi F, Moghadamnia A, Momen-Beitollahi J (2010) The efficacy of paste containing Myrtus communis (Myrtle) in the management in recurrent aphthous stomatitis: a randomized controlled trial. Clin Oral Investig 14:65–70

    PubMed  Article  Google Scholar 

  42. 42.

    Samet N, Laurent C, Susarla SM, Samet-Rubinsteen N (2007) The effect of bee propolis in recurrent aphthous stomatitis. Clin Oral Investig 11:143–147

    PubMed  Article  Google Scholar 

  43. 43.

    Braga PC, Alfieri M, Culici M, Dalsasso M (2007) Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae. Mycoses 50:502–506

    PubMed  Article  CAS  Google Scholar 

  44. 44.

    Giordani R, Regli P, Kaloustian J, Mikail C, Abou L, Portugal H (2004) Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oils from thymus vulgaris. Phytother Res 18:990–995

    PubMed  Article  CAS  Google Scholar 

  45. 45.

    Warnke PH, Sherry E, Russo PA, Acil Y, Wiltfang J, Sivananthan S, Sprengel M, Roldan JC, Schubert S, Bredee JP, Springer IN (2006) Antibacterial essential oils in malodorous cancer patients: clinical observations in 30 patients. Phytomedicine 13:463–467

    PubMed  Article  CAS  Google Scholar 

  46. 46.

    Braga PC, Sasso MD, Culici M, Alfieri M (2007) Eugenol and thymol alone or in combination induce alterations in the envelope of Candida albicans. Fitoterapia 78:396–400

    PubMed  Article  CAS  Google Scholar 

  47. 47.

    Bulut Y, Güven M, Otlu B, yenisehirli G, Aladag I, Eyibilen A, Dogru S (2007) Acute otitis media and respiratory viruses. Eur J Pediatr 166:223–228

    PubMed  Article  Google Scholar 

  48. 48.

    Damoiseaux RA, Van Balen FA, Hoes AW, deMelker RA (1998) Antibiotic treatment of acute otitis media in children under two years of age: evidence based? Br J Gen Pract 48:1861–1864

    PubMed  CAS  Google Scholar 

  49. 49.

    Glasziou PP, DelMar CB, Sanders SL, Hayem M (2004) Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 1:CD000219

    PubMed  Google Scholar 

  50. 50.

    McCormick DP, Chonmaitree T, Pittman C, Saeed K, Friedman NR, Uchida T, Baldwin CD (2005) Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics 115:1455–1465

    PubMed  Article  Google Scholar 

  51. 51.

    Sarrell EM, Mandelberg A, Cohen HA (2001) Efficacy of naturopathic extracts in the management of ear pain associated with acute otitis media. Arch Pediatr Adolesc Med 155:796–799

    PubMed  CAS  Google Scholar 

  52. 52.

    Sarrell EM, Cohen HA, Kahan E (2003) Naturopathic treatment for ear pain in children. Pediatrics 111:574–579

    Article  Google Scholar 

  53. 53.

    Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448–1456

    PubMed  Article  Google Scholar 

  54. 54.

    Bespalov VG, Alexandrov VA, Limarenko AY (2001) Chemoprevention of mammary, cervix and nervous system carcinogenesis in animals using cultured Panax ginseng drugs and preliminary clinical trials in patients with precancerous lesions of the esophagus and endometrium. J Korean Med Sci 16:42–53

    Google Scholar 

  55. 55.

    Shin HR, Kim JY, Yun TK, Morgan G, Vainio H (2000) The cancer preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control 11:565–576

    PubMed  Article  CAS  Google Scholar 

  56. 56.

    Sehn E, Hernandes L, Franco SL, Goncalves CC, Baesso ML (2009) Dynamics of reepithelialisation and penetration rate of a bee propolis formulation during cutaneous wound healing. Anal Chim Acta 635:115–120

    PubMed  Article  CAS  Google Scholar 

  57. 57.

    Bardy J, Slevin NJ, Mais KL, Molasiottis A (2008) A systematic review of honey uses and its potential value with oncologic care. J Clin Nurs 17:2661–2664

    Article  Google Scholar 

  58. 58.

    Jull AB, Rodgers A, Walker N (2008) Honey as a topical treatment for wounds. Cochrane Database Syst Rev 4:CD005083

    PubMed  Google Scholar 

  59. 59.

    Robson V, Dodd S, Thomas S (2009) Standardized antibacterial honey (Medihoney) with standard therapy in wound care: randomized clinical trial. J Adv Nurs 65:565–575

    PubMed  Article  Google Scholar 

  60. 60.

    Bialoszewski D, Kowalewski M (2003) Superficially, longer, intermittent ozone therapy in the treatment of the chronic, infected wounds. Ortop Traumatol Rehabil 5:652–658 (Polish)

    PubMed  Google Scholar 

  61. 61.

    Kim HS, Noh SU, Han YW, Kim KM, Kang H, Kim HO, Park YM (2009) Therapeutic effects of topical application of ozone on acute cutaneous wound healing. J Korean Med Sci 24:368–374

    PubMed  Article  CAS  Google Scholar 

  62. 62.

    Skomro P, Opalko K, Gadomska-Krasny J, Lietz-Kijak D, Perzanowska-Stefanska M (2005) Ozone therapy with the Ozonytrone apparatus. Ann Acad Med Stetin 52:39–42 (Polish)

    Google Scholar 

  63. 63.

    Valacchi G, Fortino V, Bocci V (2005) The dual action of ozone on the skin. Br J Dermatol 153:1096–1100

    PubMed  Article  CAS  Google Scholar 

  64. 64.

    Warnke PH, Becker ST, Podschun R, Sivananthan S, Springer IN, Russo PA, Wiltfang J, Fickenscher H, Sherry E (2009) The battle against multi-resistant strains: renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections. J Cranio-maxillo-fac Surg 37:392–397

    Google Scholar 

  65. 65.

    Chandran PK, Kuttan R (2008) Effect of Calendula officinalis flower extract on acute phase proteins, antioxidant defense mechanisms, and granuloma formation during thermal burns. J Clin Biochem Nutr 43:58–64

    PubMed  Article  Google Scholar 

  66. 66.

    Duran V, Matic M, Jovanovc M, Mimica N, Gajinov Z, Poljacki M, Boza P (2005) Results of the clinical examination of an ointment with marigold (Calendula officinalis) extract in the treatment of venous leg ulcers. Int J Tissue React 27:101–106

    PubMed  CAS  Google Scholar 

  67. 67.

    Grimme H, Augustin M (1999) Phytotherapy in chronic dermatoses and wounds: what is evidence? Forschende Komplementärmedizin 5(Suppl 2):5–8 (German)

    Article  Google Scholar 

  68. 68.

    McQuestion M (2006) Evidence-based skin care management in radiation therapy. Semin Oncol Nurs 22:163–173

    PubMed  Article  Google Scholar 

  69. 69.

    Pommier P, Gomez F, Sunyach MP, D’Hombres A, Carries C, Montbarbon X (2004) Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 22:1447–1453

    PubMed  Article  CAS  Google Scholar 

  70. 70.

    Melchart D, Linde K, Fischer P, Kaesmayr J (2000) Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2:CD000530

    PubMed  Google Scholar 

  71. 71.

    Schoop R, Klein P, Suter A, Johnston SL (2006) Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther 28:174–183

    PubMed  Article  Google Scholar 

  72. 72.

    Chang YS, Lee JY, Kim CW (1978) The effect of ginsenoide-triol on the postoperative recovery in gynecological patients. In: Proceedings of the second international Ginseng symposium, pp 79–84

  73. 73.

    Careddu P (1999) Motion sickness in children: results of a double-blind study with ginger (Zintona) and dimenhydrinate. Healthnotes Rev Complement Integr Med 6:102–107

    Google Scholar 

  74. 74.

    Ribenfeld D, Borzone L (1999) Randomized double-blind study comparing ginger (Zintona) with dimenhydrinate in motion sickness. Healthnotes Rev Complement Integr Med 6:98–101

    Google Scholar 

  75. 75.

    Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C (2006) The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. Am J Obstet Gynecol 194:95–99

    PubMed  Article  Google Scholar 

  76. 76.

    Chittumma P, Kaewkiattikun K, Wiriyasiriwach B (2007) Comparison of the effectiveness of ginger and vitamin B6 for the treatment of nausea and vomiting in early pregnancy: a randomized double-blind controlled trial. J Med Assoc Thailand 90:15–20

    Google Scholar 

  77. 77.

    Ernst E, Pittler MH (2000) Efficacy for ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anesth 84:367–371

    CAS  Google Scholar 

  78. 78.

    Ozgoli G, Goli M, Simbar M (2009) Effects on ginger capsules on pregnancy, nausea, and vomiting. J Altern Complement Med 15:243–246

    PubMed  Article  Google Scholar 

  79. 79.

    Smith C, Crowther C, Willson K, Hotham N, McMillian V (2004) A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy. Obstet Gynecol 103:639–645

    PubMed  Article  CAS  Google Scholar 

  80. 80.

    White B (2007) Ginger: an overview. Am Fam Phys 75:1689–1691

    Google Scholar 

  81. 81.

    Clostre F (1999) Ginkgo biloba extract (EGb 761) State of knowledge in the dawn of the year 2000. Ann Parma Francaises 57(Suppl 1):8–88 (French)

    Google Scholar 

  82. 82.

    Hamann K (2007) Special Gingko extract in cases of vertigo: a systematic review of randomised, double-blind, placebo-controlled clinical examinations. HNO 55:258–263 (German)

    PubMed  Article  Google Scholar 

Download references

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Raphael Richard Ciuman.

Rights and permissions

Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Reprints and Permissions

About this article

Cite this article

Ciuman, R.R. Phytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngology. Eur Arch Otorhinolaryngol 269, 389–397 (2012). https://doi.org/10.1007/s00405-011-1755-z

Download citation

Keywords

  • Phytotherapy
  • Naturopathy
  • Essential oils
  • Acute rhinosinusitis
  • Acute otitis media